Allergy & Immunology Doctors in Marietta, GA Accepting Medicare

4 Allergy & Immunology doctors found. Showing 1 - 4

Nancy Bonner, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2150 Northwest Pkwy Se, Suite A, Marietta, GA 30067 Phone: 888-816-7047    Fax: 888-840-1265

Stanley M Fineman, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 790 Church St Ne Ste 150, Marietta, GA 30060 Phone: 770-953-3331    Fax: 770-424-4480

Louis B Kalish, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 790 Church St Ne Ste 150, Marietta, GA 30060 Phone: 770-953-3331    Fax: 770-424-4480

Grace Chiang, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3747 Roswell Rd Ste 205, Marietta, GA 30062 Phone: 770-333-2027    Fax: 770-333-2031

News Archive

Researchers create new camera that can register fast processes in transparent specimens

Researchers from ITMO University have built a setup for recording holograms of tiny objects like living cells with a femtosecond speed. The new method allows one to reconstruct phase topography of a studied sample according to deformations that emerge in a laser pulse when it passes through the specimen.

Nordic networks to explore Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders

Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders – these are examples of diseases that will be explored by the three Nordic networks that have been granted financial support from the joint Nordic venture "Nordic Centre of Excellence Programme in Molecular Medicine".

Routine screening with echocardiogram can detect more cases of RHD

Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation.

GfK HealthCare: RRMS patients anticipate availability of new oral therapies

Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.

Read more Medical News

› Verified 4 days ago